Osaic Holdings
ELVN icon

Osaic Holdings’s Enliven Therapeutics ELVN Stock Holding History

Osaic Holdings’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$393K Buy
10,032
+9,972
+16,620% +$276K ﹤0.01% 3582
2025
Q4 		$924 Sell
60
-25
-29% -$498 ﹤0.01% 7300
2025
Q3 		$1.74K Sell
85
-64
-43% -$1.29K ﹤0.01% 7175
2025
Q2 		$2.99K Buy
+149
New +$2.82K ﹤0.01% 6797
2024
Q3 		– Sell
-15
Closed -$351 – 7443
2024
Q2 		$351 Sell
15
-1,985
-99% -$41.8K ﹤0.01% 7074
2024
Q1 		$35.2K Hold
2,000
– – ﹤0.01% 4979
2023
Q4 		$27.7K Hold
2,000
– – ﹤0.01% 5305
2023
Q3 		$27.3K Buy
2,000
+1,000
+100% +$16.8K ﹤0.01% 5382
2023
Q2 		$20.4K Buy
+1,000
New +$20.2K ﹤0.01% 5550

Other funds holding ELVN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return